INM Competitors & Alternatives
Compare InMed Pharmaceuticals Inc with similar stocks in the same industry
Drug Manufacturers - Specialty & Generic
INM
Main Stock$15.56
Tradestie Score
35
Market Cap
$5.29M
Revenue Growth
-0.3%
Analyst Upside
+28.5%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Major Customers
3
Rare disease clinics
Ophthalmology practices
Research institutions
Critical Suppliers
3
API manufacturers
CROs
Cannabinoid precursors
Direct Ecosystem Rivals
1
Top Competitors
47 stocks in Drug Manufacturers - Specialty & Generic| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ESPR
Esperion Therapeutics, Inc.
|
$3.18
|
$584.71M | - | 53 | Compare |
|
ETON
Eton Pharmaceutcials, Inc. Common Stock
|
$63.93
|
$543.32M | 39.9 | 33 | Compare |
|
TKNO
Alpha Teknova, Inc. Common Stock
|
$8.21
|
$340.89M | - | 38 | Compare |
|
IRWD
Ironwood Pharmaceuticals, Inc. - Class A
|
$4.83
|
$237.15M | 5.4 | 35 | Compare |
|
CRBP
Corbus Pharmaceuticals Holdings, Inc.
|
$3.39
|
$159.81M | - | 41 | Compare |
|
SPRC
SciSparc Ltd. Ordinary Shares
|
$0.35
|
$9.78M | 0.0 | 51 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.42
|
$7.21M | - | 67 | Compare |
|
QNRX
Quoin Pharmaceuticals, Ltd. American Depositary Shares
|
$3.70
|
$4.25M | 9.1 | 44 | Compare |
|
REVB
Revelation Biosciences, Inc. Common Stock
|
$4.27
|
$3.42M | - | 29 | Compare |
|
NUWE
Nuwellis, Inc. Common Stock
|
$4.90
|
$2.90M | 0.0 | 34 | Compare |
More INM Analysis
Data updated: Nov 15, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)
47 stocks in this industry